Technical Comparison
NVIDIA Corporation - Common Stock vs PharmaCyte Biotech, Inc. - Common Stock
Real-time financial comparison matrix between NVDA and PMCB.
Primary Asset
NVD
NVIDIA Corporation - Common Stock
Market Rank #101Live Price$225.30
Market Capitalization$5.5T
24h Change+0.54%
Circulating Supply24B NVDA
Comparison Asset
PMC
PharmaCyte Biotech, Inc. - Common Stock
Market Rank #1003826Live Price$0.55
Market Capitalization$5.9M
24h Change-3.41%
Circulating Supply11M PMCB
Market Metric Matrix
| Comparison Metric | NVDA Value | PMCB Value | Dominant Asset |
|---|---|---|---|
| Market Cap Rank | #101 | #1003826 | NVIDIA Corporation - Common Stock |
| Unit Price Valuation | $225.30 | $0.55 | NVIDIA Corporation - Common Stock |
| Total Liquid Cap | $5.5T | $5.9M | NVIDIA Corporation - Common Stock |
Frequently Asked Questions
Is NVIDIA Corporation - Common Stock bigger than PharmaCyte Biotech, Inc. - Common Stock?
NVIDIA Corporation - Common Stock has a market cap of $5.5T, while PharmaCyte Biotech, Inc. - Common Stock sits at $5.9M. Therefore, NVIDIA Corporation - Common Stock is currently the larger financial asset by market capitalization.
What is the price ratio between NVIDIA Corporation - Common Stock and PharmaCyte Biotech, Inc. - Common Stock?
Currently, 1 NVDA is worth 409.64 PMCB.